Focusing on 505(b)(2) new drug and high barrier / patentable generics development.
Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche drug. The company’s overall business strategy comprises of utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China) through US subsidiaries and Hangzhou Handa Pharmaceutical Technology Co., Ltd., respectively.
We specialize in controlled-release prescription pharmaceutical products that are difficult to formulate. Our business model includes managing all aspects of the product development process through the submission of its Abbreviated New Drug Applications (ANDA) and 505(b)(2) New Drug Applications (NDA) to the United States Food and Drug Administration (FDA).